Anondita Medicare gets CMSS purchase order for 5,60,43,400 pieces of condoms
Anondita Medicare · Personal Products
Key highlights
- Purchase order dated November 05, 2026, from Central Medical Services Society, Ministry of Health and Family Welfare, Government of India
- Supply of condoms, nature stated as Free Supply / Pieces [60]; the filing states a quantity of 5,60,43,400 pieces and no rupee value
- Tranche I: 50% delivery within 90 days of PO date; Tranche II: balance 50% within 91-180 days, not before 91 days
Why it's rated notable: The filing states a quantity of 5,60,43,400 pieces but no rupee value, so the level stays at medium against annual revenue of ₹137 crore.
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Bagging/Receiving of orders/contracts
Read the filing on NSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Anondita Medicare
Other order win filings this fortnight
- Batliboi Limited reports Q2 & H1 FY27 financial results and Penta Automation acquisition
- VA TECH WABAG H1 FY27 PAT Rs. 1,947 Mn, up 29% YoY; order book Rs. 202 Bn
- Danish Power Limited reports strong H1 FY27 financials and announces ₹200 crore capacity expansion
- Saatvik Green Energy reports Q2 FY27 results; Odisha facility starts commercial production
- STL Networks Limited awarded ₹555 Cr order by Power Grid Corporation India
- Marine Electricals Q2 FY27 revenue up 82% to Rs. 405 crore; new orders Rs. 2,059 crore
Potential multibaggers · Q2 FY27
Potential multibaggers in Personal Products
on management's own guidance
- Strong growth2
- 1
- Honasa Consumer LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.
